| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Merck & Co., Inc. (MRK) has 26 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. MRK is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 456.9K | $51.95M | - | |
| VP | 197.9K | $22.49M | - | |
| Dir | 108.3K | $12.31M | - | |
| Pres | 96.8K | $11.00M | - | |
| CFO | 94.2K | $10.71M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2024 | Davis Robert M46 | Chairman, CEO &President | Sale+OE | 235,021 | $125.69 | $29,538,998.07 | -18.0% | +2.9% | -31.1% | |
| Feb 13, 2024 | Romanelli Joseph57 | President, Human Health Int?l | Sell | 1,000 | $124.89 | $124,887.90 | -4.9% | +3.7% | -29.8% | |
| Feb 9, 2024 | Li Dean Y73 | Executive VP &President, Mrl | Sale+OE | 14,702 | $125.50 | $1,845,083.36 | -24.1% | +4.5% | -28.5% | |
| Feb 7, 2024 | Williams David Michael | EVP,Chief Info&Digital Officer | Sell | 1,451 | $127.57 | $185,108.28 | -6.8% | +2.9% | -29.0% | |
| Feb 2, 2024 | Oosthuizen Johannes Jacobus | President, U.s. Market | Sale+OE | 18,959 | $127.17 | $2,411,110.82 | -44.8% | +2.1% | -19.7% | |
| Feb 2, 2024 | Zachary Jennifer | EVP, General Counsel | Sale+OE | 49,499 | $126.97 | $6,284,779.13 | -63.0% | +2.1% | -19.7% | |
| Feb 2, 2024 | Mizell Steven50 | EVP, Chief Hr Officer | Sale+OE | 50,694 | $126.65 | $6,420,349.48 | -68.2% | +2.1% | -19.7% | |
| Nov 9, 2023 | Oosthuizen Johannes Jacobus | President, U.s. Market | Sell | 2,081 | $102.38 | $213,061.31 | -10.3% | +25.4% | +3.2% | |
| Nov 8, 2023 | Deluca Richard R.45 | EVP&Pres, Merck Animal Heallth | Sell | 43,823 | $105.03 | $4,602,668.34 | -28.2% | +22.4% | -0.5% | |
| Aug 14, 2023 | Mizell Steven50 | EVP, Chief Hr Officer | Sell | 4,250 | $109.01 | $463,292.50 | -15.6% | -5.3% | +7.8% |